Paper36036748
Involvement of microRNAs and their potential diagnostic, therapeutic, and prognostic role in hepatocellular carcinoma.
Zhou Y and 3 others. J Clin Lab Anal, 2022. Cited by 21 papers, by iCite.
Cite this record
ConductScience Library. Involvement of microRNAs and their potential diagnostic, therapeutic, and prognostic role in hepatocellular carcinoma. Papers, record 36036748. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36036748
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Involvement of microRNAs and their potential diagnostic, therapeutic, and prognostic role in hepatocellular carcinoma.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma, Hepatocellular | Major topic |
| Liver Neoplasms | Major topic |
| MicroRNAs | Major topic |
| 3' Untranslated Regions | |
| Biomarkers, Tumor | |
| Gene Expression Regulation, Neoplastic | |
| Humans | |
| Prognosis |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| JCZ20132 | Science and Technology Project of Nantong City | PubMed | ||
| 20KJA310011 | Natural Science Foundation of Jiangsu Higher Education Institutions of China | PubMed | ||
| Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) | PubMed |
Source PubMed
References131
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30854869 | Forms of diagnostic material as sources of miRNA biomarkers in hepatocellular carcinoma: a preliminary study. | Biomark Med | 2019 | https://conductscience.org/library/papers/30854869 | PubMed |
| 2 | 28718426 | Targeting TGF-β Signaling in Cancer. | Trends Cancer | 2017 | https://conductscience.org/library/papers/28718426 | PubMed |
| 3 | 33080466 | WNT/β-catenin signaling in the development of liver cancers. | Biomed Pharmacother | 2020 | https://conductscience.org/library/papers/33080466 | PubMed |
| 4 | 32238921 | Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours. | Br J Cancer | 2020 | https://conductscience.org/library/papers/32238921 | PubMed |
| 5 | 31806407 | Circulating microRNAs (miR-21, miR-223, miR-885-5p) along the clinical spectrum of HCV-related chronic liver disease in Egyptian patients. | Arab J Gastroenterol | 2019 | https://conductscience.org/library/papers/31806407 | PubMed |
| 6 | 32313144 | miR-486-3p mediates hepatocellular carcinoma sorafenib resistance by targeting FGFR4 and EGFR. | Cell Death Dis | 2020 | https://conductscience.org/library/papers/32313144 | PubMed |
| 7 | 31402791 | TGFβ1- miR-140-5p axis mediated up-regulation of Flap Endonuclease 1 promotes epithelial-mesenchymal transition in hepatocellular carcinoma. | Aging (Albany NY) | 2019 | https://conductscience.org/library/papers/31402791 | PubMed |
| 8 | 27577856 | MicroRNAs miR-125b and miR-100 suppress metastasis of hepatocellular carcinoma by disrupting the formation of vessels that encapsulate tumour clusters. | J Pathol | 2016 | https://conductscience.org/library/papers/27577856 | PubMed |
| 9 | 31306658 | Dicer1 facilitates liver regeneration in a manner dependent on the inhibitory effect of miR-21 on Pten and Rhob expression. | Life Sci | 2019 | https://conductscience.org/library/papers/31306658 | PubMed |
| 10 | 31576658 | microRNA-1914, which is regulated by lncRNA DUXAP10, inhibits cell proliferation by targeting the GPR39-mediated PI3K/AKT/mTOR pathway in HCC. | J Cell Mol Med | 2019 | https://conductscience.org/library/papers/31576658 | PubMed |
| 11 | 32275316 | MicroRNA-1271-5p inhibits cell proliferation and enhances radiosensitivity by targeting CDK1 in hepatocellular carcinoma. | J Biochem | 2020 | https://conductscience.org/library/papers/32275316 | PubMed |
| 12 | 18508316 | Upregulation of miR-23a approximately 27a approximately 24 decreases transforming growth factor-beta-induced tumor-suppressive activities in human hepatocellular carcinoma cells. | Int J Cancer | 2008 | https://conductscience.org/library/papers/18508316 | PubMed |
| 13 | 35669101 | miR-138-5p Inhibits Vascular Mimicry by Targeting the HIF-1α/VEGFA Pathway in Hepatocellular Carcinoma. | J Immunol Res | 2022 | https://conductscience.org/library/papers/35669101 | PubMed |
| 14 | 25306489 | Circulating microRNAs as markers of liver inflammation, fibrosis and cancer. | J Hepatol | 2014 | https://conductscience.org/library/papers/25306489 | PubMed |
| 15 | 23401231 | MicroRNA-140-5p suppresses tumor growth and metastasis by targeting transforming growth factor β receptor 1 and fibroblast growth factor 9 in hepatocellular carcinoma. | Hepatology | 2013 | https://conductscience.org/library/papers/23401231 | PubMed |
| 16 | 30503931 | MicroRNA-181a-5p suppresses cell proliferation by targeting Egr1 and inhibiting Egr1/TGF-β/Smad pathway in hepatocellular carcinoma. | Int J Biochem Cell Biol | 2019 | https://conductscience.org/library/papers/30503931 | PubMed |
| 17 | 22211142 | Promising Candidate Urinary MicroRNA Biomarkers for the Early Detection of Hepatocellular Carcinoma among High-Risk Hepatitis C Virus Egyptian Patients. | J Cancer | 2012 | https://conductscience.org/library/papers/22211142 | PubMed |
| 18 | 30805592 | MiRNA-206 inhibits hepatocellular carcinoma cell proliferation and migration but promotes apoptosis by modulating cMET expression. | Acta Biochim Biophys Sin (Shanghai) | 2019 | https://conductscience.org/library/papers/30805592 | PubMed |
| 19 | 26843134 | MicroRNA-26b Enhances the Radiosensitivity of Hepatocellular Carcinoma Cells by Targeting EphA2. | Tohoku J Exp Med | 2016 | https://conductscience.org/library/papers/26843134 | PubMed |
| 20 | 26865249 | miRNA Deregulation in Cancer Cells and the Tumor Microenvironment. | Cancer Discov | 2016 | https://conductscience.org/library/papers/26865249 | PubMed |
Cited by18
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 21 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42351723 | HCV-Induced Hepatocarcinogenesis: Molecular Mechanisms, Persistent Cancer Risk, and Future Perspectives. | Biomedicines | 2026 | https://conductscience.org/library/papers/42351723 | PubMed |
| 41483090 | A systematic review of MicroRNA (miRNA) biomarkers in the diagnosis and prognosis of hepatocellular carcinoma. | Ir J Med Sci | 2026 | https://conductscience.org/library/papers/41483090 | PubMed |
| 41107348 | Comprehensive analysis of LncRNA-miRNA-mRNA CeRNA network associated with umbilical cord blood PBMC in down syndrome. | Sci Rep | 2025 | https://conductscience.org/library/papers/41107348 | PubMed |
| 40429981 | Preliminary Evaluation of Plasma circ_0009910, circ_0027478, and miR-1236-3p as Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40429981 | PubMed |
| 40214698 | Development of a model combining CEUS LI-RADS and clinical features for predicting glypican-3 expression in hepatocellular carcinoma. | Abdom Radiol (NY) | 2025 | https://conductscience.org/library/papers/40214698 | PubMed |
| 39524833 | Network pharmacology and bioinformatic integrative analysis reveals candidate gene targets and potential therapeutic of East Kalimantan propolis against hepatocellular carcinoma. | Heliyon | 2024 | https://conductscience.org/library/papers/39524833 | PubMed |
| 39350987 | Construction and evaluation of a liver cancer risk prediction model based on machine learning. | World J Gastrointest Oncol | 2024 | https://conductscience.org/library/papers/39350987 | PubMed |
| 39158763 | An ultrasensitive electrochemical biosensor with dual-amplification mode and enzyme-deposited silver for detection of miR-205-5p. | Mikrochim Acta | 2024 | https://conductscience.org/library/papers/39158763 | PubMed |
| 39120319 | The Role of the MiR-181 Family in Hepatocellular Carcinoma. | Cells | 2024 | https://conductscience.org/library/papers/39120319 | PubMed |
| 39061656 | Recent Advances in Biosensor Technology for Early-Stage Detection of Hepatocellular Carcinoma-Specific Biomarkers: An Overview. | Diagnostics (Basel) | 2024 | https://conductscience.org/library/papers/39061656 | PubMed |
| 38991028 | Revealing the dynamic whole transcriptome landscape of Clonorchis sinensis: Insights into the regulatory roles of noncoding RNAs and microtubule-related genes in development. | PLoS Negl Trop Dis | 2024 | https://conductscience.org/library/papers/38991028 | PubMed |
| 38774201 | The role of microRNAs in hepatocellular carcinoma: Therapeutic targeting of tumor suppressor and oncogenic genes. | Clin Exp Hepatol | 2023 | https://conductscience.org/library/papers/38774201 | PubMed |
| 38707447 | Serum tRF-33-RZYQHQ9M739P0J as a novel biomarker for auxiliary diagnosis and disease course monitoring of hepatocellular carcinoma. | Heliyon | 2024 | https://conductscience.org/library/papers/38707447 | PubMed |
| 38075204 | miRNA and lncRNA as potential tissue biomarkers in hepatocellular carcinoma. | Noncoding RNA Res | 2024 | https://conductscience.org/library/papers/38075204 | PubMed |
| 37835660 | Novel Y RNA-Derived Fragments Can Differentiate Canine Hepatocellular Carcinoma from Hepatocellular Adenoma. | Animals (Basel) | 2023 | https://conductscience.org/library/papers/37835660 | PubMed |
| 36600989 | The Novel Action of miR-193b-3p/CDK1 Signaling in HCC Proliferation and Migration: A Study Based on Bioinformatic Analysis and Experimental Investigation. | Int J Genomics | 2022 | https://conductscience.org/library/papers/36600989 | PubMed |
| 36411681 | Effect of miRNA-200b on the proliferation of liver cancer cells via targeting SMYD2/p53 signaling pathway. | Zhong Nan Da Xue Xue Bao Yi Xue Ban | 2022 | https://conductscience.org/library/papers/36411681 | PubMed |
| 36036748 | Involvement of microRNAs and their potential diagnostic, therapeutic, and prognostic role in hepatocellular carcinoma. | J Clin Lab Anal | 2022 | https://conductscience.org/library/papers/36036748 | PubMed |
Genes142
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36036748
GET https://conductscience.org/api/papers/v1/36036748/references?page=2